首页> 外国专利> UCCR, a marker for diagnosing liver cancer and predicting patient survival, a kit including the same, and prediction of liver cancer patient survival using the marker

UCCR, a marker for diagnosing liver cancer and predicting patient survival, a kit including the same, and prediction of liver cancer patient survival using the marker

机译:UCCR,一种诊断肝癌和预测患者生存的标志物,包括该试剂盒的试剂盒,并使用该标志物预测肝癌患者的生存率

摘要

A composition for detecting a marker for the diagnosis or prognosis of liver cancer is disclosed. The composition includes an agent capable of assessing the expression level of UQCRH (ubiquinol-cytochrome c reductase hinge protein). In addition, a kit having the composition, a microarray for the diagnosis of liver cancer using the marker, and a method for detecting the marker, and predicting recurrence following surgery in liver cancer patients are disclosed. The marker is able to contribute to the early diagnosis of liver cancer and prediction of recurrence following surgery and survival of liver cancer patients who have undergone hepatic resection, and also is significant for being a promising therapeutic target for liver cancer.
机译:公开了用于检测用于诊断或预后肝癌的标志物的组合物。该组合物包含能够评估UQCRH(泛醇-细胞色素c还原酶铰链蛋白)表达水平的试剂。另外,公开了一种试剂盒,其具有所述组成,使用所述标志物诊断肝癌的微阵列,以及检测所述标志物并预测肝癌患者手术后复发的方法。该标记物能够有助于肝癌的早期诊断和预测肝切除术后肝癌患者的手术和生存后的复发,并且对于成为有希望的肝癌治疗靶标也具有重要意义。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号